Financhill
Back

Coinbase Global Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
61

COIN
Coinbase Global

Last Price:
225.99
Seasonality Move:
33.06%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
61
Coinbase Global (COIN) is a Buy

Is Coinbase Global a Buy, Sell or Hold?

  • The current Coinbase Global [COIN] share price is $226.17. The Score for COIN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • COIN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

COIN Stock Price Chart

What is Coinbase Global's stock price today?

  • The Coinbase Global share price today is $226.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COIN is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

COIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.88 Buy
Relative Strength Index (14 RSI): 44.9 Sell
Chaikin Money Flow: 4415555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (222.24 - 249.74) Sell
Bollinger Bands (100): (178.56 - 256.58) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

COIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 241.69 Sell
20-day SMA: 240.52 Sell
50-day SMA: 228.21 Sell
200-day SMA: 163.27 Buy
8-day EMA: 238.33 Sell
20-day EMA: 237.76 Sell
50-day EMA: 230.51 Sell
200-day EMA: 178.48 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Coinbase Global Earnings Growth & COIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.44 per share, an increase next quarter of $0.35 per share, an increase this year of $8.25 per share, and a decrease next year of $3.23 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Coinbase Global Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):